Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium is a research paper published in Journal of Clinical Oncology (2020). On theSindex it has a DataRank of 1.0. It has been cited 800 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
1.0
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCI NIH HHS
Grant: P30 CA016672
NCI NIH HHS
Grant: P30 CA076292
NCI NIH HHS
Grant: K23 CA201594
National Institutes of Health
Grant: 1K23CA201594-01
Breaking immune tolerance to Survivin in Multiple Myeloma
National Institutes of Health
Grant: 3P30CA016672-41S4
Cancer Center Support (CORE) Grant
National Institutes of Health
Grant: 3P30CA076292-24S2
Moffitt Cancer Center Support Grant
FWCI
37.17
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals